XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 80 filers reported holding XENON PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $567,122 | +61.6% | 14,383 | +48.0% | 0.03% | +54.5% |
| Q3 2022 | $351,000 | -49.3% | 9,717 | -57.3% | 0.02% | -12.0% |
| Q2 2022 | $692,000 | -31.0% | 22,747 | -30.7% | 0.02% | -35.9% |
| Q1 2022 | $1,003,000 | +253.2% | 32,805 | +261.2% | 0.04% | +200.0% |
| Q4 2021 | $284,000 | +31.5% | 9,083 | -35.8% | 0.01% | +8.3% |
| Q3 2021 | $216,000 | +6.4% | 14,150 | +24.9% | 0.01% | +20.0% |
| Q1 2021 | $203,000 | +9.7% | 11,330 | -30.4% | 0.01% | -23.1% |
| Q1 2020 | $185,000 | – | 16,286 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 790,000 | $12,071,000 | 3.53% |
| GREAT POINT PARTNERS LLC | 700,000 | $10,696,000 | 2.49% |
| COMMODORE CAPITAL LP | 579,432 | $8,854,000 | 2.33% |
| ACUTA CAPITAL PARTNERS, LLC | 417,409 | $6,378,000 | 2.25% |
| DAFNA Capital Management LLC | 406,535 | $6,212,000 | 1.65% |
| Tri Locum Partners LP | 264,134 | $4,036,000 | 1.60% |
| Parkman Healthcare Partners LLC | 311,207 | $4,755,000 | 1.20% |
| Ghost Tree Capital, LLC | 250,000 | $3,820,000 | 1.12% |
| Nan Fung Group Holdings Ltd | 197,880 | $3,024,000 | 0.97% |
| BVF INC/IL | 1,571,778 | $24,017,000 | 0.94% |